1. Home
  2. ELUT vs JHI Comparison

ELUT vs JHI Comparison

Compare ELUT & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • JHI
  • Stock Information
  • Founded
  • ELUT 2015
  • JHI 1971
  • Country
  • ELUT United States
  • JHI United States
  • Employees
  • ELUT 54
  • JHI N/A
  • Industry
  • ELUT Medical Specialities
  • JHI Trusts Except Educational Religious and Charitable
  • Sector
  • ELUT Health Care
  • JHI Finance
  • Exchange
  • ELUT Nasdaq
  • JHI Nasdaq
  • Market Cap
  • ELUT 145.2M
  • JHI 124.3M
  • IPO Year
  • ELUT 2020
  • JHI N/A
  • Fundamental
  • Price
  • ELUT $4.20
  • JHI $13.89
  • Analyst Decision
  • ELUT Strong Buy
  • JHI
  • Analyst Count
  • ELUT 2
  • JHI 0
  • Target Price
  • ELUT $10.00
  • JHI N/A
  • AVG Volume (30 Days)
  • ELUT 42.1K
  • JHI 29.5K
  • Earning Date
  • ELUT 11-14-2024
  • JHI 01-01-0001
  • Dividend Yield
  • ELUT N/A
  • JHI 6.80%
  • EPS Growth
  • ELUT N/A
  • JHI N/A
  • EPS
  • ELUT N/A
  • JHI 1.05
  • Revenue
  • ELUT $24,782,000.00
  • JHI N/A
  • Revenue This Year
  • ELUT $8.00
  • JHI N/A
  • Revenue Next Year
  • ELUT $39.89
  • JHI N/A
  • P/E Ratio
  • ELUT N/A
  • JHI $12.47
  • Revenue Growth
  • ELUT N/A
  • JHI N/A
  • 52 Week Low
  • ELUT $1.86
  • JHI $11.63
  • 52 Week High
  • ELUT $5.24
  • JHI $13.40
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 52.78
  • JHI 31.53
  • Support Level
  • ELUT $3.90
  • JHI $13.84
  • Resistance Level
  • ELUT $4.40
  • JHI $14.45
  • Average True Range (ATR)
  • ELUT 0.39
  • JHI 0.09
  • MACD
  • ELUT -0.04
  • JHI -0.06
  • Stochastic Oscillator
  • ELUT 24.59
  • JHI 8.20

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About JHI John Hancock Investors Trust

John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.

Share on Social Networks: